Therapeutic Effect of Two Fluoride Varnishes on White Spot Lesions: a Clinical Study - Full Text View

Purpose

The study hypothesis is the difference in therapeutic effect of two varnish formulations (G1 = NaF, 2.26%F, G2 = NaF, 2.71% F + CaF2). These products are commercially available in the Brazilian and international market and they are used for dental caries as white spot lesions control.

Condition	Intervention	Phase
Dental Caries	Drug: sodium fluoride Drug: sodium fluoride calcium fluoride	Phase 4


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Participant) Primary Purpose: Treatment
Official Title:	Therapeutic Effect of Two Fluoride Varnishes on White Spot Lesions: a Clinical Study

Resource links provided by NLM:

MedlinePlus related topics: Rashes Tooth Decay

Drug Information available for: Sodium fluoride Fluorine Fluoride Listerine

U.S. FDA Resources

Further study details as provided by University of Pernambuco:

Primary Outcome Measures:

reduction of the size of the caries lesion [ Time Frame: 4 weeks ]

Secondary Outcome Measures:

Inactivation of carious lesions [ Time Frame: 4 weeks ]


Enrollment:	45
Study Start Date:	February 2007
Study Completion Date:	October 2007
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Active Comparator: G1 NaF (sodium fluoride varnish) with 2.26% of fluoride	Drug: sodium fluoride sodium fluoride 5% Other Name: Duraphat®, Colgate Palmolive GmbH, Hamburg, Germany
Experimental: G2 NaF (sodium fluoride)2.71% of fluoride plus CaF2 (calcium fluoride)	Drug: sodium fluoride calcium fluoride sodium fluoride 5% + calcium fluoride Other Name: Duofluorid XII®, FGM, Joinville, Brazil

Detailed Description:

The aim of this study was to evaluate the therapeutic effect of two varnish formulations (G1 = NaF, 2.26%F, G2 = NaF, 2.71% F + CaF2) on the remineralization of white spot lesions (WSL). The sample was composed of 15 (7- to 12-year-old) children with 45 active WSL in anterior permanent teeth. The children were randomly divided in two groups providing 22 lesions for G1 and 23 for G2. The children were submitted to weekly varnish applications 4 times. The WSL were evaluated twice: baseline and on week 4. Maximum lesion dimensions (mesial-distal and incisal-gingival) were measured in millimeters and classified in four grades of size. WSL were also recorded assessing lesion activity by one calibrated examiner. The Pearson chi-square and Fisher's exact tests were used (P < 0.01). WSL reductions were observed in both varnish groups (Chi-square= 0.15, d.f.=1, P=0.90); and with similar magnitude (in mm): 1.19 and 1.29 for G1 and G2, respectively. Thirty-six WLS (15 in G1 and 26 in G2) were classified as inactive in week 4 reaching an overall value of 80%. No difference was observed between G1 and G2 regarding activity scores (Fisher's exact test, p > 0.01). It can be concluded that after 4 applications the two varnish formulations tested produced similar clinical effects indicating the reduction and the control of carious activity in most WSL.

Eligibility


Ages Eligible for Study:	7 Years to 12 Years (Child)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

regular hygiene habits (brushing teeth everyday)
registered in public schools

Exclusion Criteria:

dental caries such as small cavities or restorations in the target teeth (permanent anterior teeth)
development enamel alterations (hypoplasia, fluorosis) or periodontal disease
children using orthodontic devices
under medical treatment
taking any kind of medicine
no informed consent form signed

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00723515

Locations


Brazil
University of Pernambuco
Camaragibe, Pernambuco, Brazil, 54753-220

Sponsors and Collaborators

University of Pernambuco

Investigators


Principal Investigator:	Jainara MS Ferreira, Master	University of Pernambuco
Study Chair:	Ana Karla R Aragão, Graduate	Univeristy of Pernambuco
Study Chair:	Adriana DB Rosa, student	Federal University of Paraiba
Study Chair:	Fabio C Sampaio, PhD	Federal Univerisity of Paraiba
Study Chair:	Valdenice A Menezes, PhD	Univeristy of Pernambuco

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ferreira JM, Aragão AK, Rosa AD, Sampaio FC, Menezes VA. Therapeutic effect of two fluoride varnishes on white spot lesions: a randomized clinical trial. Braz Oral Res. 2009 Oct-Dec;23(4):446-51.


Responsible Party:	Jainara Maria Soares Ferreira, University of Pernambuco
ClinicalTrials.gov Identifier:	NCT00723515 History of Changes
Other Study ID Numbers:	UPE 260/08
Study First Received:	July 24, 2008
Last Updated:	July 24, 2008

Keywords provided by University of Pernambuco:


White spot lesion Tooth remineralization Fluoride varnishes

Additional relevant MeSH terms:


Dental Caries Tooth Demineralization Tooth Diseases Stomatognathic Diseases Calcium, Dietary Fluorides, Topical Sodium Fluoride Fluorides	Listerine Bone Density Conservation Agents Physiological Effects of Drugs Cariostatic Agents Protective Agents Anti-Infective Agents, Local Anti-Infective Agents

ClinicalTrials.gov processed this record on June 27, 2017